• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back

what is type 2 diabetes

deficit in insulin and decrease in tissue sensitivity to insulin


insulin resistance


increased glucose production in the liver


poor beta cell function

what are the drugs for type 2 diabetes

Biguanides (Metformin)


Sulfonylureas


Thiazolidinediones


DPP-IV Inhibitors


SGLT2 Inhibtors


Meglitinide Analogs


Alpha-glucosidase Inhibitors


GLP-1 agonists

ADR of biguanides

GI: nausea, indigestion, abdominal cramps, bloating, diarrhea, or combo

who are bad candidates for biguanides

renal impariment (1.4ml/dl)


heart failure


uncontrolled respiratory disease

dose for biguanides

Metformin


500mg T BID with meals

ADR of sulfonylureas

low rate: HA, nausea, hypoglycemia


cardiovascular mortality



drug:drug interactions: NSAIDs, BB, warfarin increase hypoglycemic effect, thiazides, steroids, thyroid preps, estrogen decrease hypoglycemic effect


dose for sulfonylureas

Glimepiride


1mg T qd with breakfast

ADR of thiazolidendiones

NO hypoglycemia


rare liver issues (check q 2mo)


fluid retention

dose for thiazolidendiones

Pioglitazone


15mg T qd

what DPP-IV inhibitors need renal impairment dosing adjustments

Alogliptin (Nesina)


Saxagliptin (Onglyza)


Sitagliptin (Januvia)

which DPP-IV inhibitors can cause drug interactions

Saxagliptin (Onglyza)


Lingliptin (tradjenta)

ADR of DPP-IV inhibitors

low


nasopharyngitis, URI


allergic rxn

dose for DPP-IV inhibitors

Januvia


100mg qd

ADR of GLP-1 receptor agonists

GI: n/v/d


delay in gastic emptying time


renal issues

dose for GLP-1 receptor agonists

Victoza


18mg/3mL


inject 1.2mg SQ qd

ADR of SGLT2 inhibitors

HOTN (from dehydration)


hyperkalemia


infx (UTI, genital mycotic infx)


increase in LDL-C


increase in blade and breast CA risk

dose for SGLT2 inhibitors

Invokana


300mg T qd

dose for meglitinide analogs

Prandin


0.5mg T before each meal

ADR of alpha-glucosidase inhibitor

diarrhea, abd pain, flatulence


hypoglycemia risk is gone unless pt uses insulin or sulfonylurea

dose for alpha-glucosidase inhibitor

Precose


100mg T with first bite of a meal